Trademark: RAPIVAB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for RAPIVAB
We do not have any records of a proof of use for RAPIVAB at this moment.
Possible trademark infringements of RAPIVAB
Basic Information about RAPIVAB
- Serial Number
- 86141883
- Filing Date
- 12 Dec 2013
- Registration Number
- 4778059
- Registration Date
- 21 Jul 2015
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RAPIVAB on the blockchain with WikiTrademarks.io.
- First use of RAPIVAB anywhere
- RAPIVAB was first used on 15 Jan 2015 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns RAPIVAB?
1. BIOCRYST PHARMACEUTICALS, INC. DURHAM NC
2. SEQIRUS UK LIMITED Durham NC
3. BioCryst Pharmaceuticals, Inc. Birmingham AL
4. BioCryst Pharmaceuticals, Inc. Birmingham AL
5. BioCryst Pharmaceuticals, Inc. Birmingham AL
Correspondent
- Erica L. Han Ropes & Gray LLP
- Prudential Tower, 800 Boylston Street
- Boston, MA 02199-3600
- UNITED STATES
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io